SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-029887
Filing Date
2022-10-28
Accepted
2022-10-28 17:20:40
Documents
12
Period of Report
2022-10-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40614
  Complete submission text file 0001493152-22-029887.txt   218150

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lctx-20221026.xsd EX-101.SCH 3042
3 XBRL LABEL FILE lctx-20221026_lab.xml EX-101.LAB 35156
4 XBRL PRESENTATION FILE lctx-20221026_pre.xml EX-101.PRE 23035
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3756
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12830 | Film No.: 221343011
SIC: 2836 Biological Products, (No Diagnostic Substances)